123 related articles for article (PubMed ID: 37423567)
21. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
23. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of the post-radiotherapy
Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
26. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19.
Hanneman K; Houbois C; Schoffel A; Gustafson D; Iwanochko RM; Wintersperger BJ; Chan R; Fish JE; Howe KL; Thavendiranathan P
JAMA Cardiol; 2022 Mar; 7(3):298-308. PubMed ID: 35019953
[TBL] [Abstract][Full Text] [Related]
27. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy.
Lota AS; Hazebroek MR; Theotokis P; Wassall R; Salmi S; Halliday BP; Tayal U; Verdonschot J; Meena D; Owen R; de Marvao A; Iacob A; Yazdani M; Hammersley DJ; Jones RE; Wage R; Buchan R; Vivian F; Hafouda Y; Noseda M; Gregson J; Mittal T; Wong J; Robertus JL; Baksi AJ; Vassiliou V; Tzoulaki I; Pantazis A; Cleland JGF; Barton PJR; Cook SA; Pennell DJ; Garcia-Pavia P; Cooper LT; Heymans S; Ware JS; Prasad SK
Circulation; 2022 Oct; 146(15):1123-1134. PubMed ID: 36154167
[TBL] [Abstract][Full Text] [Related]
28. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET in malignant lymphoma: significance of positive findings.
Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
[TBL] [Abstract][Full Text] [Related]
30. Patterns of [18F]FDG myocardial uptake in oncology patients as a predictor of myocardial ischaemia on stress myocardial perfusion imaging.
Fathala A; Alsugair A; Abouzied M; Almuhaideb A
Nucl Med Rev Cent East Eur; 2021; 24(2):51-57. PubMed ID: 34382668
[TBL] [Abstract][Full Text] [Related]
31. Clinical implication of myocardial FDG uptake pattern in oncologic PET: retrospective comparison study with stress myocardial perfusion imaging as the reference standard.
Takanami K; Saito M; Matsumoto Y; Sugimura K; Takase K
Ann Nucl Med; 2020 Apr; 34(4):233-243. PubMed ID: 31981092
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
[TBL] [Abstract][Full Text] [Related]
33. 18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy.
Tessier R; Marteau L; Vivien M; Guyomarch B; Thollet A; Fellah I; Jamet B; Sébille JC; Eugene T; Serfaty JM; Probst V; Trochu JN; Toquet C; Warin-Fresse K; Piriou N
Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014065. PubMed ID: 35770631
[No Abstract] [Full Text] [Related]
34. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Campisi R; Merani MF; Rodríguez MI
Curr Cardiol Rep; 2022 Dec; 24(12):1873-1882. PubMed ID: 36282434
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.
Aoyama R; Takano H; Kobayashi Y; Kitamura M; Asai K; Amano Y; Kumita SI; Shimizu W
PLoS One; 2017; 12(11):e0188479. PubMed ID: 29176885
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
38. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
[TBL] [Abstract][Full Text] [Related]
40. Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.
Farquharson AL; Chopra A; Ford A; Matthews S; Amin SN; De Noronha R
Colorectal Dis; 2012 Feb; 14(2):e56-63. PubMed ID: 21831171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
